title: [Peculiarities of cytokine status in patients with vitiligo and stress in anamnesis].
abstract: The aim of our study was to investigate the content of some proinflammatory cytokines (IL-2, IL-6) in the serum of patients with vitiligo and stress in anamnesis. Cytokine levels in serum were measured in 50 patients with vitiligo (20 men and 30 women aged from 18 to 65 years old.) All the patients were divided according to anamnesis (27 patients with stress in anamnesis and 23 patients, where the onset of the disease was not preceded by stress). Patients of both groups were similar in terms of shape (according to T. Fitzpatrick classification) and in terms of the dermatosis stages. Concomitant autoimmune or inflammatory diseases of the skin in our vitiligo patients were not observed. The cytokines in the blood serum of vitiligo patients were determined by ELISA using the corresponding monoclonal antibodies. Student's t-test was used for evaluation of statistical significance of received results (p < 0.05 was considered as a statistically significant). Content of IL-2 in the serum of patients with vitiligo, in which stress was not preceded dermatosis, was significantly higher than that in healthy individuals (25,5 ± 7,6 vs 10,5 ± 3,6 pg/ml, p < 0,05). But the same parameter in patients with stress in anamnesis was significantly lower than those in healthy individuals (3,5 ± 1,5 vs 10,5 ± 3,6 pg/l, p < 0.05). Changes in the content of IL-6 in the serum of vitiligo patients was a similar to changes in IL-2 content, and the most significant this indicator was in patients with generalized and progressive stage of the disease. Data on increased concentrations of IL-6 agree with the majority of studies conducted earlier. For a complete analysis of our results on the reduction of the cytokines (IL-2, IL-6) content in patients with a stress in anamnesis, that will allow to identify the most effective ways to treat patients with this pathology (including their cytokine status), further research is necessary.
authors.affiliation: Tbilisi State Medical University, Department of Dermatology and Venerology; "Georgian Assotiation of VITILIGO", Tbilisi, Georgia.
authors.forename: N V
authors.initials: NV
authors.lastname: Tsiskarishvili
authors.affiliation: Tbilisi State Medical University, Department of Dermatology and Venerology; "Georgian Assotiation of VITILIGO", Tbilisi, Georgia.
authors.forename: A
authors.initials: A
authors.lastname: Katsitadze
authors.affiliation: Tbilisi State Medical University, Department of Dermatology and Venerology; "Georgian Assotiation of VITILIGO", Tbilisi, Georgia.
authors.forename: N I
authors.initials: NI
authors.lastname: Tsiskarishvili
authors.affiliation: Tbilisi State Medical University, Department of Dermatology and Venerology; "Georgian Assotiation of VITILIGO", Tbilisi, Georgia.
authors.forename: L
authors.initials: L
authors.lastname: Chitanava
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013315:Stress, Psychological / Q000097:blood* / Q000503:physiopathology; D014820:Vitiligo / Q000097:blood* / Q000503:physiopathology
chemical_list: D007376:Interleukin-2; D015850:Interleukin-6